Free Trial

Warby Parker (WRBY) Competitors

Warby Parker logo
$24.29 +0.11 (+0.45%)
(As of 12/17/2024 ET)

WRBY vs. PEN, GKOS, BLCO, INSP, PRCT, AXNX, NVCR, NVST, NARI, and IRTC

Should you be buying Warby Parker stock or one of its competitors? The main competitors of Warby Parker include Penumbra (PEN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), Axonics (AXNX), NovoCure (NVCR), Envista (NVST), Inari Medical (NARI), and iRhythm Technologies (IRTC). These companies are all part of the "medical equipment" industry.

Warby Parker vs.

Warby Parker (NYSE:WRBY) and Penumbra (NYSE:PEN) are both mid-cap consumer staples companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, valuation, community ranking, risk, earnings, media sentiment, institutional ownership and dividends.

Warby Parker has a beta of 1.93, meaning that its share price is 93% more volatile than the S&P 500. Comparatively, Penumbra has a beta of 0.51, meaning that its share price is 49% less volatile than the S&P 500.

Warby Parker currently has a consensus target price of $20.73, suggesting a potential downside of 14.67%. Penumbra has a consensus target price of $254.15, suggesting a potential upside of 2.68%. Given Penumbra's stronger consensus rating and higher possible upside, analysts clearly believe Penumbra is more favorable than Warby Parker.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Warby Parker
0 Sell rating(s)
4 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.67
Penumbra
0 Sell rating(s)
4 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.80

Penumbra has a net margin of 2.97% compared to Warby Parker's net margin of -4.39%. Penumbra's return on equity of 8.99% beat Warby Parker's return on equity.

Company Net Margins Return on Equity Return on Assets
Warby Parker-4.39% -8.26% -4.37%
Penumbra 2.97%8.99%6.80%

Penumbra received 779 more outperform votes than Warby Parker when rated by MarketBeat users. Likewise, 80.27% of users gave Penumbra an outperform vote while only 42.86% of users gave Warby Parker an outperform vote.

CompanyUnderperformOutperform
Warby ParkerOutperform Votes
39
42.86%
Underperform Votes
52
57.14%
PenumbraOutperform Votes
818
80.27%
Underperform Votes
201
19.73%

93.2% of Warby Parker shares are owned by institutional investors. Comparatively, 88.9% of Penumbra shares are owned by institutional investors. 26.5% of Warby Parker shares are owned by company insiders. Comparatively, 5.0% of Penumbra shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Warby Parker and Warby Parker both had 20 articles in the media. Penumbra's average media sentiment score of 0.81 beat Warby Parker's score of 0.61 indicating that Penumbra is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Warby Parker
8 Very Positive mention(s)
3 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Penumbra
8 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Positive

Penumbra has higher revenue and earnings than Warby Parker. Warby Parker is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Warby Parker$742.53M3.33-$63.20M-$0.27-89.96
Penumbra$1.16B8.16$90.95M$0.86287.80

Summary

Penumbra beats Warby Parker on 15 of the 18 factors compared between the two stocks.

Get Warby Parker News Delivered to You Automatically

Sign up to receive the latest news and ratings for WRBY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WRBY vs. The Competition

MetricWarby ParkerOphthalmic goods IndustryStaples SectorNYSE Exchange
Market Cap$2.46B$11.21B$14.53B$19.67B
Dividend YieldN/A1.63%2.65%3.51%
P/E Ratio-89.9641.8022.9843.79
Price / Sales3.335.292.7817.64
Price / CashN/A16.6921.1421.73
Price / Book7.893.425.975.46
Net Income-$63.20M$235.23M$580.19M$987.68M
7 Day Performance3.23%-0.44%-1.44%-2.32%
1 Month Performance6.44%-3.82%1.81%0.63%
1 Year Performance105.50%5.70%6.04%16.39%

Warby Parker Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WRBY
Warby Parker
1.6879 of 5 stars
$24.29
+0.5%
$20.73
-14.7%
+106.2%$2.46B$742.53M-89.963,491Analyst Forecast
PEN
Penumbra
4.2025 of 5 stars
$247.98
+1.0%
$252.42
+1.8%
+0.8%$9.52B$1.16B285.524,200Analyst Forecast
GKOS
Glaukos
4.1648 of 5 stars
$143.91
+3.6%
$143.17
-0.5%
+79.6%$7.93B$360.35M-46.00780Short Interest ↓
BLCO
Bausch + Lomb
2.2616 of 5 stars
$18.58
-0.1%
$20.58
+10.8%
+24.3%$6.54B$4.68B-17.7113,300Short Interest ↑
INSP
Inspire Medical Systems
4.6937 of 5 stars
$188.20
+0.2%
$233.58
+24.1%
+1.4%$5.64B$755.59M176.781,011Short Interest ↓
Positive News
PRCT
PROCEPT BioRobotics
3.0564 of 5 stars
$89.44
+0.2%
$97.86
+9.4%
+104.0%$4.67B$136.19M0.00626Positive News
AXNX
Axonics
1.1641 of 5 stars
$70.98
+0.8%
$71.00
+0.0%
+21.8%$3.63B$366.38M-591.45610High Trading Volume
NVCR
NovoCure
2.87 of 5 stars
$32.84
-1.7%
$32.67
-0.5%
+136.7%$3.55B$577.74M-23.861,453
NVST
Envista
3.621 of 5 stars
$19.52
+0.3%
$20.65
+5.8%
-19.3%$3.36B$2.50B-2.5112,800Positive News
NARI
Inari Medical
2.544 of 5 stars
$55.46
-0.2%
$58.89
+6.2%
-13.5%$3.25B$574.50M-41.181,300Analyst Forecast
IRTC
iRhythm Technologies
3.0394 of 5 stars
$89.29
+3.3%
$107.82
+20.8%
-9.5%$2.79B$492.68M-17.782,000

Related Companies and Tools


This page (NYSE:WRBY) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners